DAPIS Online Remote Access (DORA) is a web based real time prescription monitoring system that will provide prescribers and pharmacists secure access to clinical information for their patients relating to controlled medicines.
ACT DORA will be made available to pharmacists and prescribers from March 2019.
A prescriber or pharmacist will be able to look up information in DORA for any ACT patient that presents to them. Information displayed will include patient details as well as their controlled medicine dispensing history and any ACT prescriber approvals that are in place for them.
DORA is an extension of the Drugs and Poisons Information System (DAPIS), which is used by the ACT Health Protection Service (HPS) as its prescription monitoring system.
Why use DORA?
Australia has a growing national problem with the misuse and abuse of pharmaceuticals. The number of harms including deaths from prescription medicines has increased and is now higher than illegal drugs.
DORA is intended to be a clinical support tool for prescribers and pharmacists, to enable them to better identify and manage patients who may be exhibiting signs of drug dependency or drug seeking behaviours, such as ‘doctor shopping’.
DORA is being introduced to improve the safety of ACT patients by giving prescribers and pharmacists valuable information before they write or dispense a prescription for a controlled medicine.
DORA is not intended to disadvantage patients where there is a legitimate clinical need for a medicine and where a prescriber is authorised to prescribe a controlled medicine for a person.
How can a pharmacist or prescriber access DORA?
Any prescriber of controlled medicines and pharmacists may apply to access DORA to support ACT patient care. Prescribers include doctors, dentists and some nurse practitioners.
Using DORA is not mandatory, however ACT Health urges all eligible prescribers and pharmacists to use DORA as a new part of their clinical practice, with the aim of minimising harms associated with the use and misuse of controlled medicines.
From March 2019, prescribers and pharmacists will be able to apply to register for DORA via the DORA registration website. Applicants will also need to provide a range of verification documents to the HPS to complete their registration. This will include a copy of their AHPRA certificate, 100 points of ID and their organisation or practice’s Public Key Infrastructure (PKI) certificate.
Further details will be provided to prescribers and pharmacists about the registration process when DORA becomes available from March 2019.
Security of patient records in DORA
The ACT Government is committed to ensuring the security of patient information within DORA. DORA has undergone rigorous security testing and complies with the ACT Government Protective Security Policy Framework and the ICT Security Policy.
A record in DORA is a health record and is protected by law under the Health Records (Access and Privacy) Act 1997. The Medicines, Poisons and Therapeutic Goods Act 2008 also outlines acceptable use provisions and offences related to this information. Strict penalties apply for any person found to be inappropriately accessing or using DORA information.
Real time reporting from pharmacies
Most of the information in DORA will be displayed in real time, immediately after a prescription is dispensed from a pharmacy in the ACT.
All ACT community pharmacies are currently able to report dispensing information to DORA via their dispensing software. Dispensing information from hospital pharmacies will still appear in DORA, however there may be a time lag in the information being viewable.
All ACT pharmacies are required to report information for all controlled medicine dispensing events to ACT Health at least each week, in accordance with the Medicines, Poisons and Therapeutic Goods Act 2008.
Visit the real time reporting page for further information.
How can I find out more about DORA?
Detailed information about DORA for consumers and health professionals is being developed and will be provided when DORA becomes available from March 2019.
Detailed training packages will be made available for prescribers and pharmacists when DORA is introduced.